Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-07-12.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Jun 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Netherlands B.V. | 12 Jul 2024 | Biologics | On file |
| Henogen | 24 Oct 2023 | Biologics | |
| Minaris Regenerative Medicine, LLC | 25 Sep 2023 | Biologics | On file |
| Bristol-Myers Squibb Company | 5 May 2023 | Biologics | On file |
| Gilead Sciences, Inc. | 22 Jul 2022 | Biologics |
Sites inspected
Lonza Netherlands B.V.Geleen, Netherlands1 insp.
HenogenSeneffe, Belgium1 insp.
Minaris Regenerative Medicine, LLCAllendale, United States1 insp.
Bristol-Myers Squibb CompanyDevens, United States1 insp.
Gilead Sciences, Inc.Oceanside, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Phillip C Thai2 shared
Christine Harman2 shared
Zhongren Wu2 shared
Donald B Ertel2 shared
Timothy Kamaldinov1 shared
Carl A Perez1 shared
Jie He1 shared
Takele H Argaw1 shared
Alan G Baer1 shared
Zainab Y Mansaray-Storms1 shared
Full investigator report
Get the verbatim findings behind Graeme E Price's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site